Collagenases in cancer

Biochimie

Volumn 87, Issue 3-4 SPEC. ISS., 2005, Pages 273-286

  Ala Aho, Risto ^a   Kähäri, Veli Matti ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cancer; Collagenase; Matrix metalloproteinase; Metastasis

Indexed keywords

AE 941; BISPHOSPHONIC ACID DERIVATIVE; COLLAGENASE; COLLAGENASE 3; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUTROPHIL COLLAGENASE; STAT PROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

3' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; BONE METASTASIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; DRUG BIOAVAILABILITY; ENZYME SUBSTRATE; GENE EXPRESSION REGULATION; HUMAN; LUNG NON SMALL CELL CANCER; METAMORPHOSIS; METASTASIS INHIBITION; NONHUMAN; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA STABILITY; TADPOLE; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 15244338619     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2004.12.009     Document Type: Short Survey

References (165)

1. C.M. Overall, and C. López-Otín Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat. Rev. Cancer 2 2002 657 672
2. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2 2002 161 174
3. R.T. Aimes, and J.P. Quigley Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments J. Biol. Chem. 270 1995 5872 5876 Mar 17
4. E. Ohuchi, K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules J. Biol. Chem. 272 1997 2446 2451
5. E.M. Tam, T.R. Moore, G.S. Butler, and C.M. Overall Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities J. Biol. Chem. 279 2004 43336 43344
6. L. Chung, D. Dinakarpandian, N. Yoshida, J.L. Lauer-Fields, G.B. Fields, R. Visse, and H. Nagase Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis EMBO J. 23 2004 3020 3030
7. V. Knäuper, C. López-Otín, B. Smith, G. Knight, and G. Murphy Biochemical characterization of human collagenase-3 J. Biol. Chem. 271 1996 1544 1550
8. A.M. Pendás, T. Matilla, X. Estivill, and C. López- Otín The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family Genomics 26 1995 615 618
9. M.A. Stolow, D.D. Bauzon, J. Li, T. Sedgwick, V.C. Liang, Q.A. Sang, and Y.B. Shi Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development Mol. Biol. Cell 10 1996 1471 1483
10. E.B. Springman, E.L. Angleton, H. Birkedal-Hansen, and H.E. Van Wart Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation Proc. Natl. Acad. Sci. USA 87 1990 364 368
11. R. Sanchez-Lopez, C.M. Alexander, O. Behrendtsen, R. Breathnach, and Z. Werb Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins J. Biol. Chem. 268 1993 7238 7247
12. V.M. Baragi, C.J. Fliszar, M.C. Conroy, Q.Z. Ye, J.M. Shipley, and H.G. Welgus Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin J. Biol. Chem. 269 1994 12692 12697
13. Q. Nguyen, F. Willenbrock, M.I. Cockett, M. O'Shea, A.J. Docherty, and G. Murphy Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A Biochemistry 33 1994 2089 2095
14. V. Knäuper, S. Cowell, B. Smith, C. López-Otín, M. O'Shea, H. Morris, L. Zardi, and G. Murphy The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction J. Biol. Chem. 272 1997 7608 7616
15. T. Hirose, C. Patterson, T. Pourmotabbed, C.L. Mainardi, and K.A. Hasty Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity Proc. Natl. Acad. Sci. USA 90 1993 2569 2573
16. F.X. Gomis-Rüth, U. Gohlke, M. Betz, V. Knäuper, G. Murphy, C. López-Otín, and W. Bode The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain J. Mol. Biol. 264 1996 556 566
17. J. Gross, and C.M. Lapìre Collagenolytic activity in amphibian tissues: a tissue culture assay Proc. Natl. Acad. Sci. USA 48 1962 1014 1022
18. G.I. Goldberg, S.M. Wilhelm, A. Kronberger, E.A. Bauer, G.A. Grant, and A.Z. Eisen Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein J. Biol. Chem. 261 1986 6600 6605
19. S.M. Wilhelm, A.Z. Eisen, M. Teter, S.D. Clarck, A. Kronberger, and G. Goldberg Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis Proc. Natl. Acad. Sci. USA 83 1986 3756 3760
20. K.A. McGowan, E.A. Bauer, and L.T. Smith Localization of type I human skin collagenase in developing embryonic and fetal skin J. Invest. Dermatol. 102 1994 951 957
21. L. Ravanti, and V.-M. Kähäri Matrix metalloproteinases in wound repair Int. J. Mol. Med. 6 2000 391 407
22. T.A. Giambernardi, G.M. Grant, G.P. Taylor, R.J. Hay, V.M. Maher, J.J. McCormick, and R.J. Klebe Overview of matrix metalloproteinase expression in cultured human cells Matrix Biol. 16 1998 483 496
23. M. Balbín, A. Fueyo, V. Knäuper, J.M. López, J. Álvarez, L.M. Sánchez, V. Quesada, J. Bordallo, G. Murphy, and C. López-Otín Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation J. Biol. Chem. 276 2001 10253 10262
24. J.M. Freije, I. Díz-Itza, M. Balbín, L.M. Sánchez, R. Blasco, J. Tolivia, and C. López-Otín Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas J. Biol. Chem. 269 1994 16766 16773
25. K.A. Hasty, M.S. Hibbs, A.H. Kang, and C.L. Mainardi Secreted forms of human neutrophil collagenase J. Biol. Chem. 261 1986 5645 5650
26. K.A. Hasty, T.F. Pourmotabbed, G.I. Goldberg, J.P. Thompson, D.G. Spinella, R.M. Stevens, and C.L. Mainardi Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases J. Biol. Chem. 265 1990 11421 11424
27. K.A. Hasty, J.J. Jeffrey, M.S. Hibbs, and H.G. Welgus The collagen substrate specificity of human neutrophil collagenase J. Biol. Chem. 262 1987 10048 10052
28. A.A. Cole, S. Chubinskaya, B. Schumacher, K. Huch, G. Cs-Szabo, J. Yao, K. Mikecz, K.A. Hasty, and K.E. Kuettner Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase J. Biol. Chem. 271 1996 11023 11026
29. R. Hanemaaijer, T. Sorsa, Y.T. Konttinen, Y. Ding, M. Sutinen, H. Visser, V.W.M. Van Hinsbergh, T. Helaakoski, T. Kainulainen, H. Rönkä, H. Tschesche, and T. Salo Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells J. Biol. Chem. 272 1997 31504 31509
30. K. Prikk, P. Maisi, E. Pirilä, R. Sepper, T. Salo, J. Wahlgren, and T. Sorsa In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis J. Pathol. 194 2001 232 238
31. M. Abe, K. Kawamoto, H. Okamoto, and N. Horiuchi Induction of collagenase-2 (matrix metalloproteinase-8) gene expression by interleukin-1β in human gingival fibroblasts J. Periodontal Res. 36 2001 153 159
32. V. Knäuper, H. Will, C. López-Otín, B. Smith, S.J. Atkinson, H. Stanton, R.M. Hembry, and G. Murphy Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme J. Biol. Chem. 271 1996 17124 17131
33. S.M. Krane, M.H. Byrne, V. Lemaitre, P. Henriet, J.J. Jeffrey, J.P. Witter, X. Liu, H. Wu, R. Jaenisch, and Y. Eeckhout Different collagenase gene products have different roles in degradation of type I collagen J. Biol. Chem. 271 1996 28509 28515
34. P.G. Mitchell, H.A. Magna, L.M. Reeves, L.L. Lopresti-Morrow, S.A. Yocum, P.J. Rosner, K.F. Geoghegan, and J.E. Hambor Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage J. Clin. Invest. 97 1996 761 768
35. J.L. Ashworth, G. Murphy, M.J. Rock, M.J. Sherratt, S.D. Shapiro, C.A. Shuttleworth, and C.M. Kielty Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling Biochem. J. 340 1999 171 181
36. A.J. Fosang, K. Last, V. Knäuper, G. Murphy, and P.J. Neame Degradation of cartilage aggrecan by collagenase-3 (MMP-13) FEBS Lett. 380 1996 17 20
37. G.A. McQuibban, G.S. Butler, J.H. Gong, L. Bendall, C. Power, I. Clark-Lewis, and C.M. Overall Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 J. Biol. Chem. 276 2001 43503 43508
38. G.A. McQuibban, J.H. Gong, E.M. Tam, C.A. McCulloch, I. Clark-Lewis, and C.M. Overall Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3 Science 289 2000 1202 1206
39. S.J. Deng, D.M. Bickett, J.L. Mitchell, M.H. Lambert, R.K. Blackburn, H.L. Carter 3rd, J. Neugebauer, G. Pahel, M.P. Weiner, and M.L. Moss Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library J. Biol. Chem. 275 2000 31422 31427
40. N. Johansson, U. Saarialho-Kere, K. Airola, R. Herva, L. Nissinen, J. Westermarck, E. Vuorio, J. Heino, and V.-M. Kähäri Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development Dev. Dyn. 208 1997 387 395
41. M. Ståhle-Bäckdahl, B. Sandstedt, K. Bruce, A. Lindahl, M. Jimenez, J. Vega, and C. López-Otín Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis Lab. Invest. 76 1997 717 728
42. L. Ravanti, L. Häkkinen, H. Larjava, U. Saarialho-Kere, M. Foschi, J. Han, and V.-M. Kähäri Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase J. Biol. Chem. 274 1999 37292 37300
43. L. Ravanti, M. Toriseva, R. Penttinen, T. Crombleholme, M. Foschi, J. Han, and V.-M. Kähäri Human collagenase-3 expression by fetal skin fibroblasts is induced by transforming growth factor-β via p38 mitogen-activated protein kinase FASEB J. 15 2001 1098 1100
44. M. Inada, Y. Wang, M.H. Byrne, M.U. Rahman, C. Miyaura, C. López-Otín, and S.M. Krane Critical roles for collagenase-3 (MMP13) in development of growth plate cartilage and in endochondral ossification Proc. Natl. Acad. Sci. U. S. A. 101 2004 17192 17197
45. D. Stickens, D.J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A.J. Fosang, M. Schorpp-Kistner, P. Angel, and Z. Werb Altered endochondral bone development in matrix metalloproteinase 13-deficient mice Development 131 2004 5883 5895
46. O. Lindy, Y.T. Konttinen, T. Sorsa, Y. Ding, S. Santavirta, A. Ceponis, and C. López-Otín Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium Arthritis Rheum. 40 1997 1391 1399
47. D. Mao, J.K. Lee, S.J. VanVickle, and R.W. Thompson Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture Biochem. Biophys. Res. Commun. 261 1999 904 910
48. P. Reboul, J.-P. Pelletier, G. Tardif, J.-M. Cloutier, and J. Martel-Pelletier The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis J. Clin. Invest. 97 1996 2011 2019
49. G.K. Sukhova, U. Schönbeck, E. Rabkin, F.J. Schoen, A.R. Poole, R.C. Billinghurst, and P. Libby Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques Circulation 99 1999 2503 2509
50. V.-J. Uitto, K. Airola, M. Vaalamo, N. Johansson, E.E. Putnins, J.D. Firth, J. Salonen, C. López-Otín, U. Saarialho-Kere, and V.-M. Kähäri Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation Am. J. Path. 152 1998 1489 1499
51. M. Vaalamo, M.-L. Karjalainen-Lindsberg, P. Puolakkainen, J. Kere, and U. Saarialho-Kere Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophagemetalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations Am. J. Pathol. 152 1998 1005 1014
52. M. Vaalamo, L. Mattila, N. Johansson, A.-L. Kariniemi, M.-L. Karjalainen-Lindsberg, V.-M. Kähäri, and U. Saarialho-Kere Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds J. Invest. Dermatol. 109 1997 96 101
53. M. Karin, Z.-G. Liu, and E. Zandi AP-1 function and regulation Curr. Opin. Cell Biol. 9 1997 240 246
54. A.D. Sharrocks, A.L. Brown, Y. Ling, and P.R. Yates The ETS-domain transcription factor family Int. J. Biochem. Cell Biol. 29 1997 1371 1387
55. C. Wasylyk, A. Gutman, R. Nicholson, and B. Wasylyk The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins EMBO J. 10 1991 1127 1134
56. J. Westermarck, A. Seth, and V.-M. Kähäri Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors Oncogene 14 1997 2651 2660
57. M. Kaya, K. Yoshida, F. Higashino, T. Mitaka, S. Ishii, and K. Fujinaga A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells Oncogene 12 1996 221 227
58. G. Buttice, M. Duterque Coquillaud, J.P. Basuyaux, S. Carrere, M. Kurkinen, and D. Stehelin Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex Oncogene 13 1996 2297 2306
59. R. Gum, E. Lengyel, J. Juarez, J.H. Chen, H. Sato, M. Seiki, and D. Boyd Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences J. Biol. Chem. 271 1996 10672 10680
60. I. Bolon, V. Gouyer, M. Devouassoux, B. Vandenbunder, N. Wernert, D. Moro, C. Brambilla, and E. Brambilla Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas Am. J. Pathol. 147 1995 1298 1310
61. I. Bolon, E. Brambilla, B. Vandenbunder, C. Robert, S. Lantuejoul, and C. Brambilla Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions Lab. Invest. 75 1996 1 13
62. N. Wernert, F. Gilles, V. Fafeur, F. Bouali, M.B. Raes, C. Pyke, C. Brambilla, and E. Brambilla Stromal expression of c-Ets1 transcription factor correlates with tumor invasion Cancer Res. 54 1994 5683 5688
63. E. Korzus, H. Nagase, R. Rydell, and J. Travis The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression J. Biol. Chem. 272 1997 1188 1196
64. J. Westermarck, S.-P. Li, T. Kallunki, J. Han, and V.-M. Kähäri mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase-1 (MMP-1) gene expression Mol. Cell. Biol. 21 2001 2373 2383 (2001) p38
65. G. Suske The Sp-family of transcription factors Gene 238 1999 291 300
66. J.A. Uría, M. Ståhle-Bäckdahl, M. Seiki, A. Fueyo, and C. López-Otín Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions Cancer Res. 57 1997 4882 4888
67. J.A. Uría, M.G. Jiḿnez, M. Balbín, J.M.P. Freije, and C. López-Otín Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts J. Biol. Chem. 273 1998 9769 9777
68. A.M. Pendás, M. Balbin, E. Llano, M.G. Jimenez, and C. López-Otín Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13) Genomics 40 1997 222 233
69. P. Ducy, R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Cell 89 1997 747 754
70. T. Komori, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto Targeted disrubtion of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 1997 755 764
71. M.J. Jiḿnez, M. Balbín, J.M. López, J. Alvarez, T. Komori, and C. Ĺpez-Otín Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation Mol. Cell. Biol. 19 1999 4431 4442
72. N. Selvamurugan, S. Kwok, T. Alliston, M. Reiss, and N.C. Partridge Transforming growth factor-β1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2 J. Biol. Chem. 279 2004 19327 19334
73. J.A. Mengshol, M.P. Vincenti, and C.E. Brinckerhoff IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways Nucleic Acids Res. 29 2001 4361 4372
74. W.S. El-Deiry, S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein Definition of a consensus binding site for p53 Nat. Genet. 1 1992 45 49
75. N. Kley, R.Y. Chung, S. Fay, J.P. Loeffler, and B.R. Seizinger Repression of the basal c-fos promoter by wild-type p53 Nucleic Acids Res. 20 1992 4083 4087
76. T. Miyashita, M. Harigai, M. Hanada, and J.C. Reed Identification of a p53-dependent negative response element in the bcl-2 gene Cancer Res. 54 1994 3131 3135
77. H. Werner, E. Karnieli, F.J. Rauscher, and D. LeRoith Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene Proc. Natl. Acad. Sci. USA 93 1996 8318 8323
78. Y. Sun, X.R. Zeng, L. Wenger, G.S. Firestein, and H.S. Cheung P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex J. Cell. Biochem. 92 2004 258 269
79. Y. Sun, L. Wenger, J.L. Rutter, C.E. Brinckerhoff, and H.S. Cheung p53 down-regulates human matrix metalloproteinase-1 (Collagenase-1) gene expression J. Biol. Chem. 274 1999 11535 11540
80. Y. Sun, J.M. Cheung, J. Martel-Pelletier, J.P. Pelletier, L. Wenger, R.D. Altman, D.S. Howell, and H.S. Cheung Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13) J. Biol. Chem. 275 2000 11327 11332
81. R. Ala-aho, R. Gŕnman, P. Seth, and V.-M. Kähäri Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells Oncogene 21 2002 1187 1195
82. M.P. Vincenti, C.I. Coon, O. Lee, and C.E. Brinckerhoff Regulation of collagenase gene expression by IL-1β requires transcriptional and post-transcriptional mechanisms Nucleic Acids Res. 22 1994 4818 4827
83. N. Reunanen, S.-P. Li, M. Ahonen, M. Foschi, J. Han, and V.-M. Kähäri Activation of p38α MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization J. Biol. Chem. 277 2002 32360 32368 (2002)
84. M.A.E. Frevel, T. Bakheet, A.M. Silva, J.G. Hissong, K.S.A. Khabar, and B.R.G. Williams p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts Mol. Cell. Biol. 23 2003 425 436
85. E. Carballo, W.S. Lai, and P.J. Blackshear Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability Blood 95 2000 1891 1899
86. W.S. Lai, E. Carballo, J.R. Strum, E.A. Kennington, R.S. Phillips, and P.J. Blackshear Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA Mol. Cell. Biol. 19 1999 4311 4323
87. G. Stoecklin, X.F. Ming, R. Looser, and C. Moroni Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway Mol. Cell. Biol. 20 2000 3753 3763
88. S. Rydziel, A.M. Delany, and E. Canalis AU-rich elements in the collagenase 3 mRNA mediate stabilization of the transcript by cortisol in osteoblasts J. Biol. Chem. 279 2004 5397 5404
89. H.E. Van Wart, and H. Birkedal-Hansen The cystein switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family Proc. Natl. Acad. Sci. USA 87 1990 5578 5582
90. K. Suzuki, J.J. Enghild, T. Morodomi, G. Salvesen, and H. Nagase Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin) Biochemistry 29 1990 10261 10270
91. A. Ito, and H. Nagase Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase Arch. Biochem. Biophys. 267 1988 211 216
92. K. Imai, Y. Yokohama, I. Nakanishi, E. Ohuchi, Y. Fujii, N. Nakai, and Y. Okada Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties J. Biol. Chem. 270 1995 6691 6697
93. J. Saarinen, N. Kalkkinen, H.G. Welgus, and P.T. Kovanen Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase J. Biol. Chem. 269 1994 18134 18140
94. M.P. D'Ortho, H. Will, S. Atkinson, G. Butler, A. Messent, J. Gavrilovic, B. Smith, R. Timpl, L. Zardi, and G. Murphy Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases Eur. J. Biochem. 250 1997 751 757
95. V. Knäuper, B. Smith, C. López-Otín, and G. Murphy Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13) Eur. J. Biochem. 248 1997 369 373
96. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J. Cell Sci. 115 2002 3719 3727
97. G.S. Butler, M. Hutton, B.A. Wattam, R.A. Williamson, V. Knäuper, F. Willenbrock, and G. Murphy The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations J. Biol. Chem. 274 1999 20391 20396
98. B. Stratmann, M. Farr, and H. Tschesche MMP-TIMP interaction depends on residue 2 in TIMP-4 FEBS Lett. 507 2001 285 287
99. P. Vihinen, and V.-M. Kähäri Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int. J. Cancer 99 2002 157 166
100. S.H. Barsky, G.P. Siegal, F. Jannotta, and L.A. Liotta Loss of basement membrane components by invasive tumors but not by their benign counterparts Lab. Invest. 49 1983 140 147
101. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat. Rev. Cancer 2 2002 563 572
102. Y. He, T. Karpanen, and K. Alitalo Role of lymphangiogenic factors in tumor metastasis Biochim. Biophys. Acta 1654 2004 3 12
103. H. Guo, S. Zucker, M.K. Gordon, B.P. Toole, and C. Biswas Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells J. Biol. Chem. 272 1997 24 27
104. G.I. Murray, M.E. Duncan, P. O'Neil, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat. Med. 2 1996 461 462
105. G.I. Murray, M.E. Duncan, E. Arbuckle, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinases and their inhibitors in gastric cancer Gut 43 1998 791 797
106. G.I. Murray, M.E. Duncan, P. O'Neil, J.A. McKay, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer J. Pathol. 185 1998 256 261
107. T. Ito, M. Ito, J. Shiozawa, S. Naito, T. Kanematsu, and I. Sekine Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor Mod. Pathol. 12 1999 669 674
108. J. Nikkola, P. Vihinen, T. Vlaykova, M. Hahka-Kemppinen, V.-M. Kähäri, and S. Pyrhönen High expression levels of collagenase-1 (MMP-1) and stromelysin-1 (MMP-3) correlate with shorter disease-free survival in human metastatic melanoma Int. J. Cancer 97 2002 432 438
109. J. Nikkola-Paakkarinen, P. Vihinen, M. Vuoristo, P. Kellokumpu-Lehtinen, V.-M. Kähäri, and S. Pyrhönen Prognostic value of serum gelatinase-B (MMP-9) and collagenase-1 (MMP-1) and collagenase-3 (MMP-13) in human metastatic melanoma Clin. Cancer Res. 2005 (In press)
110. N. Johansson, K. Airola, R. Gŕnman, A.-L. Kariniemi, U. Saarialho-Kere, and V.-M. Kähäri Expression of collagenase-3 (matrix metalloproteinase-13) in squamos cell carcinomas of the head and neck Am. J. Pathol. 151 1997 499 508
111. D. Muller, R. Breathnach, A. Engelmann, R. Millon, G. Bronner, H. Flesch, P. Dumont, M. Eber, and J. Abecassis Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours Int. J. Cancer 48 1991 550 556
112. M. Polette, C. Clavel, D. Muller, J. Abecassis, I. Binninger, and P. Birembaut Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization Invasion Metastasis 11 1991 76 83
113. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Käkönen, C. Cordon-Cardo, T.A. Guise, and J. Massagú A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
114. J.L. Rutter, T.I. Mitchell, G. Buttice, J. Meyers, J.F. Gusella, L.J. Ozelius, and C.E. Brinckerhoff A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription Cancer Res. 58 1998 5321 5325
115. G. Ghilardi, M.L. Biondi, J. Mangoni, S. Leviti, M. DeMonti, E. Guagnellini, and R. Scorza Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness Clin. Cancer Res. 7 2001 2344 2346
116. Y. Kanamori, M. Matsushima, T. Minaguchi, K. Kobayashi, S. Sagae, R. Kudo, N. Terakawa, and Y. Nakamura Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region Cancer Res. 59 1999 4225 4227
117. Y. Nishioka, K. Kobayashi, S. Sagae, S. Ishioka, A. Nishikawa, M. Matsushima, Y. Kanamori, T. Minaguchi, Y. Nakamura, T. Tokino, and R. Kudo A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas Jpn. J. Cancer Res. 91 2000 612 615
118. M. Moilanen, E. Pirilä, R. Gŕnman, T. Sorsa, and T. Salo Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinoma J. Pathol. 197 2002 72 81
119. S. Stadlmann, J. Pollheimer, P.L. Moser, A. Raggi, A. Amberger, R. Margreiter, F.A. Offner, G. Mikuz, S. Dirnhofer, and H. Moch Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer Eur. J. Cancer 39 2003 2499 2505
120. M. Balbín, A. Fueyo, A.M. Tester, A.M. Pendás, A.S. Pitiot, A. Astudillo, C.M. Overall, S.D. Shapiro, and C. López-Otín Loss of collagenase-2 confers increased skin tumor susceptibility to male mice Nat. Genet. 35 2003 252 257
121. B.S. Nielsen, F. Rank, J.M. Loṕz, M. Balbín, F. Vizoso, L.R. Lund, K. Danø, and C. López-Otín Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas Cancer Res 61 2001 7091 7100
122. K. Airola, N. Johansson, A.-L. Kariniemi, V.-M. Kähäri, and U. Saarialho-Kere Human collagenase-3 is expressed in malignant squamous epithelium of the skin J. Invest. Dermatol. 109 1997 225 231
123. M. Cazorla, L. Hernandez, A. Nadal, M. Balbín, J.M. López, F. Vizoso, P.L. Fernandez, K. Iwata, A. Cardesa, C. López-Otín, and E. Campo Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx J. Pathol. 186 1998 144 150
124. N. Johansson, M. Vaalamo, S. Gŕnman, S. Hietanen, P. Klemi, U. Saarialho-Kere, P.L. Fernandez, K. Iwata, A. Cardesa, C. López- Otín, and E. Campo Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas Am. J. Pathol. 154 1999 469 480
125. T. Etoh, H. Inoue, Y. Yoshikawa, G.F. Barnard, S. Kitano, and M. Mori Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness Gut 47 2000 50 56
126. J.A. Uría, M. Balbín, J.M. López, J. Alvarez, F. Vizoso, M. Takigawa, and C. López-Otín Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor Am. J. Pathol. 153 1998 91 101
127. K. Airola, T. Karonen, M. Vaalamo, K. Lehti, J. Lohi, A.L. Kariniemi, J. Keski-Oja, U.K. Saarialho-Kere, and U.K. Saarialho-Kere Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas Br. J. Cancer 80 1999 733 743
128. J. Nikkola, P. Vihinen, T. Vlaykova, M. Hahka-Kemppinen, V.-M. Kähäri, and S. Pyrhönen High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma Melanoma Res. 11 2001 157 166
129. P.J. Boström, L. Ravanti, N. Reunanen, V. Aaltonen, K.-O. Söderström, V.-M. Kähäri, and M. Laato Expression of collagenase-3 (matrix metalloproteinase-13) in transitional cell carcinoma of the urinary bladder Int. J. Cancer 88 2000 417 423
130. N. Johansson, J. Westermarck, S. Leppä, L. Häkkinen, L. Koivisto, C. López-Otín, J. Peltonen, J. Heino, and V.-M. Kähäri Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT Keratinocytes is enchanced by tumor necrosis factor-α and transforming growth factor-β Cell Growth Differ. 8 1997 243 250
131. R. Ala-aho, M. Ahonen, S.J. George, J. Heikkilä, R. Gŕnman, M. Kallajoki, and V.-M. Kähäri Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo Oncogene 23 2004 5111 5123
132. R. Ala-aho, N. Johansson, R. Gŕnman, N.E. Fusenig, C. López-Otín, and V.-M. Kähäri Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-γ is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1 Oncogene 19 2000 248 257
133. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13 2001 534 540
134. W.C. Parks, C.L. Wilson, and Y.S. Lopez-Boado Matrix metalloproteinases as modulators of inflammation and innate immunity Nat. Rev. Immunol. 4 2004 617 629
135. F. Sabeh, I. Ota, K. Holmbeck, H. Birkedal-Hansen, P. Soloway, M. Balbin, C. López-Otín, S. Shapiro, M. Inada, S. Krane, E. Allen, D. Chung, and S.J. Weiss Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP J. Cell Biol. 167 2004 769 781
136. R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis Nat. Rev. Cancer 3 2003 422 433
137. M. Hidalgo, and S.G. Eckhardt Development of matrix metalloproteinase inhibitors in cancer therapy J. Natl. Cancer Inst. 93 2001 178 193
138. P. Vihinen, R. Ala-aho, and V.M. Kähäri Matrix metalloproteinases as therapeutic targets in cancer Curr. Cancer Drug Targets 2005 (In press)
139. S.R. Bramhall, M.T. Hallissey, J. Whiting, J. Scholefield, G. Tierney, R.C. Stuart, R.E. Hawkins, P. McCulloch, T. Maughan, P.D. Brown, M. Baillet, and J.W. Fielding Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial Br. J. Cancer 86 2002 1864 1870
140. E.K. Rowinsky, R. Humphrey, L.A. Hammond, C. Aylesworth, L. Smetzer, M. Hidalgo, M. Morrow, L. Smith, A. Garner, J.M. Sorensen, D.D. Von Hoff, and S.G. Eckhardt Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies J. Clin. Oncol. 18 2000 178 186
141. B.L. Lokeshwar, E. Escatel, and B. Zhu Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3) Curr. Med. Chem. 8 2001 271 279
142. B.L. Lokeshwar, M.G. Selzer, B.Q. Zhu, N.L. Block, and L.M. Golub Inhibition of cell4proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model Int. J. Cancer 98 2002 297 309
143. R.E. Seftor, E.A. Seftor, J.E. De Larco, D.E. Kleiner, J. Leferson, W.G. Stetler-Stevenson, M. Morrow, L. Smith, A. Garner, J.M. Sorensen, D.D. Von Hoff, and S.G. Eckhardt Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis Clin. Exp. Metastasis 16 1998 217 225
144. P.D. Delmas Bisphosphonates in the treatment of bone diseases N. Engl. J. Med. 335 1996 1836 1837
145. O. Teronen, P. Heikkilä, Y.T. Konttinen, M. Laitinen, T. Salo, R. Hanemaaijer, A. Teronen, P. Maisi, and T. Sorsa MMP inhibition and downregulation by bisphosphonates Ann. N. Y. Acad. Sci. 878 1999 453 465
146. D. Gingras, A. Renaud, N. Mousseau, E. Beaulieu, Z. Kachra, and R. Beliveau Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound Anticancer Res. 21 2001 145 155
147. R. Ala-aho, N. Johansson, A.H. Baker, and V.-M. Kähäri Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells Int. J. Cancer 97 2002 283 289
148. M. Ahonen, A.H. Baker, and V.-M. Kähäri Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells Cancer Res. 58 1998 2310 2315
149. M. Ahonen, R. Ala-aho, A.H. Baker, S.J. George, R. Gŕnman, U. Saarialho-Kere, and V.-M. Kähäri Antitumor activity and by-stander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3 Mol. Ther. 6 2002 705 715
150. K. Brand, A.H. Baker, A. Perez-Canto, A. Possling, M. Sacharjat, M. Geheeb, and W. Arnold Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue Cancer Res. 60 2000 5723 5730
151. M. Bloomston, A. Shafii, E.E. Zervos, and A.S. Rosemurgy TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis J. Surg. Res. 102 2002 39 44
152. M. Wang, Y.E. Liu, J. Greene, S. Sheng, A. Fuchs, E.M. Rosen, and Y.E. Shi Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4 Oncogene 14 1997 2767 2774
153. M.Y. Celiker, M. Wang, E. Atsidaftos, X. Liu, Y.E. Liu, Y. Jiang, E. Valderrama, I.D. Goldberg, and Y.E. Shi Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA Oncogene 20 2001 4337 4343
154. N. Johansson, R. Ala-aho, V. Uitto, R. Gŕnman, N.E. Fusenig, C. López-Otín, and V.-M. Kähäri Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase J. Cell Sci. 113 2000 227 235
155. G.L. Clayman, A.K. El-Naggar, J.A. Roth, W.W. Zhang, H. Goepfert, D.L. Taylor, and T.J. Liu In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma Cancer Res. 55 1995 1 6
156. G.L. Clayman, A.K. El-Naggar, S.M. Lippman, Y.C. Henderson, M. Frederick, J.A. Merritt, L.A. Zumstein, T.M. Timmons, T.J. Liu, L. Ginsberg, J.A. Roth, W.K. Hong, P. Bruso, and H. Goepfert Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma J. Clin. Oncol. 16 1998 2221 2232
157. G.L. Clayman, D.K. Frank, P.A. Bruso, and H. Goepfert Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers Clin. Cancer Res. 5 1999 1715 1722
158. T.J. Liu, W.W. Zhang, D.L. Taylor, J.A. Roth, H. Goepfert, and G.L. Clayman Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus Cancer Res. 54 1994 3662 3667
159. T.J. Liu, A.K. El-Naggar, T.J. McDonnell, K.D. Steck, M. Wang, D.L. Taylor, and G.L. Clayman Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck Cancer Res. 55 1995 3117 3122
160. D.P. Lane, and S. Lain Therapeutic exploitation of the p53 pathway Trends Mol. Med. 8 2002 S38 S42
161. S. Hasegawa, N. Koshikawa, N. Momiyama, K. Moriyama, Y. Ichikawa, T. Ishikawa, M. Mitsuhashi, H. Shimada, and K. Miyazaki Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model Int. J. Cancer 76 1998 812 816
162. W. James, and A. Al-Shamkhani RNA enzymes as tools for gene ablation Curr. Opin. Biotechnol. 6 1995 44 49
163. C.M. Flory, P.A. Pavco, T.C. Jarvis, M.E. Lesch, F.E. Wincott, L. Beigelman, S.W. Hunt 3rd, and D.J. Schrier Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint Proc. Natl. Acad. Sci. USA 93 1996 754 758
164. J. Hua, and R.J. Muschel Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system Cancer Res. 56 1996 5279 5284
165. L. Nakopoulou, I. Giannopoulou, H. Gakiopoulou, H. Liapis, A. Tzonou, and P.S. Davaris Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features Hum. Pathol. 30 1999 436 442